[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Probiotics Market by Product Type (Functional Food & Beverages (FnB), Dietary Supplements, and Feed), Ingredient (Bacteria and Yeast), End User (Human and Animal), Distribution Channel and Region - Global Forecast to 2029

March 2024 | 342 pages | ID: P211F6611D5EN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to MarketsandMarkets, the Probiotics market is projected to reach USD 105.7 billion by 2029 from USD 71.2 billion by 2024, at a CAGR of 8.2% during the forecast period in terms of value. Dietary supplements present consumers with a straightforward and hassle-free means to integrate probiotics into their daily regimen. With formats ranging from tablets to capsules and chewable, these supplements require no preparation and can be easily stored at room temperature, catering to the demands of modern, fast-paced lifestyles. This convenience factor resonates strongly with busy individuals seeking an effortless solution to bolster gut health, thereby driving sustained demand for dietary probiotic supplements.

Moreover, the appeal of dietary supplements extends beyond convenience to encompass precise dosing capabilities, allowing consumers to tailor their probiotic intake to address specific health concerns. Through targeted formulations containing distinct probiotic strains, consumers can effectively manage digestive health, support immune function, and even promote mental well-being. The realm of dietary supplements further thrives on innovation, with personalized formulations combining probiotics with complementary ingredients such as prebiotics or vitamins gaining traction.

Additionally, emerging advancements such as chewable tablets and timed-release capsules enhance consumer choice and efficacy, positioning dietary supplements as a cornerstone of proactive health management within the evolving probiotics market landscape.

' By distribution channel, Online is estimated to grow with the highest CAGR during the forecast period.'

Online channels are poised to experience significant growth in the distribution of probiotics, outpacing traditional brick-and-mortar outlets. According to data from the U.S. Food and Drug Administration (FDA) released in October 2022, online sales of dietary supplements, including probiotics, have witnessed a substantial surge, particularly among younger demographics. This trend is propelled by several factors, including the unparalleled convenience offered by online retailers, allowing consumers to browse and purchase probiotics from the comfort of their homes at any time, thus eliminating the need for physical store visits.

Moreover, e-commerce platforms boast a wider product selection compared to traditional stores, offering diverse probiotic brands, formulations, and international options, catering to varied consumer preferences. This shift towards online channels is further reinforced by government initiatives such as India's Digital India program, which aims to facilitate safe and secure online transactions for health and wellness products, including probiotics.

Furthermore, subscription models and personalized recommendations offered by online retailers enhance consumer engagement and loyalty. Consumers can opt for subscription services for recurring probiotic deliveries, ensuring a steady supply of products. Advanced e-commerce platforms leverage user data to provide personalized recommendations tailored to individual needs and health goals

“Europe will significantly contribute towards market growth during the forecast period.”

Europe is positioned as a pivotal contributor to the burgeoning probiotics market throughout the forecasted period. Spearheaded by prominent industry leaders such as Probi (Sweden), Nestlй (Switzerland), AB-Biotics, S.A. (Belgium), Danone (France), BioGaia (Sweden), and Adisseo (France) with headquarters and robust market presence in the region, Europe stands as a stronghold of innovation and consumer engagement. For instance, in December 2023 Eurobarometer survey conducted by the European Commission highlighted a burgeoning understanding of the gut microbiome's pivotal role in overall well-being. This heightened awareness translates into a surging demand for diverse probiotic products, spanning from digestive health aids to immune-boosting supplements and solutions for mental well-being, thus fueling market expansion.

Moreover, Europe benefits from a supportive regulatory landscape established by the European Union (EU), mandating stringent scientific substantiation of health claims associated with probiotics. This regulatory rigor ensures a level of quality and transparency within the market, bolstering consumer confidence and fostering sustained market growth.

Break-up of Primaries:

By Company Type: Tier1-40%, Tier 2-32%, Tier 3- 28%

By Designation: C-level-45%, D-level – 33%, and Others- 22%

By Region: North America - 15%, Europe - 20%, Asia Pacific – 40%, South America-12%, RoW – 13%,

Others include sales managers, territory managers, and product managers.

Leading players profiled in this report:
  • Probi (Sweden)
  • Nestlй (Switzerland)
  • ADM (US)
  • Danone (France)
  • International Flavors & Fragrances Inc. (US)
  • Yakult Honsha Co., Ltd. (Japan)
  • BioGaia (Sweden)
  • MORINAGA MILK INDUSTRY CO., LTD. (Japan)
  • Meiji Holdings Co., Ltd. (Japan)
  • Lifeway Foods, Inc. (US)
  • Adisseo (France)
  • Winclove Probiotics (US)
  • AB-Biotics, S.A. (Belgium)
  • Apsen Farmac?utica (Brazil)
  • Lallemand (Canada)
  • Elanco (US)
  • NextFoods, Inc.(US)
  • i-Health, Inc. (US)
  • Suja Life LLC. (US)
  • Renew Life Formulas LLC. (US)
  • BIOHM Health (US)
  • Sun Genomics (US)
  • Unique Biotech Ltd (India)
  • So Good So You (US)
  • Protocol For Life Balance (US)
The study includes an in-depth competitive analysis of these key players in the Probiotics market with their company profiles, recent developments, and key market strategies.

Research Coverage:

The report segments the Probiotics market on the basis of product type, ingredient, distribution channel, end user, and region. In terms of insights, this report has focused on various levels of analyses—the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the global Probiotics market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall probiotics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:
  • Analysis of key drivers (Health benefits associated with probiotic-fortified foods), restraints (High R&D costs for developing new probiotic strains), opportunities (Replacement of pharmaceutical agents by probiotics), and challenges (Complexities in integrating probiotics in functional foods) influencing the growth of the Probiotics market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Probiotics market.
  • Market Development: Comprehensive information about lucrative markets – the report analyses the Probiotics market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Probiotics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players Probi (Sweden), Nestlй (Switzerland), ADM (US), Danone (France), International Flavors & Fragrances Inc. (US), and Yakult Honsha Co., Ltd. (Japan), among others in the Probiotics market strategies. The report also helps stakeholders understand the Probiotics market and provides them with information on key market drivers, restraints, challenges, and opportunities.
1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
  1.3.1 MARKET SEGMENTATION
FIGURE 1 PROBIOTICS MARKET SEGMENTATION
  1.3.2 INCLUSIONS AND EXCLUSIONS
  1.3.3 REGIONS COVERED
FIGURE 2 PROBIOTICS MARKET SEGMENTATION, BY REGION
  1.3.4 YEARS CONSIDERED
FIGURE 3 STUDY PERIODS CONSIDERED
1.4 UNITS CONSIDERED
  1.4.1 CURRENCY (VALUE UNIT)
TABLE 1 USD EXCHANGE RATES CONSIDERED, 2019–2022
  1.4.2 VOLUME UNIT
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT ANALYSIS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 4 PROBIOTICS MARKET: RESEARCH DESIGN
  2.1.1 SECONDARY DATA
    2.1.1.1 Key data from secondary sources
FIGURE 5 KEY DATA FROM SECONDARY SOURCES
  2.1.2 PRIMARY DATA
    2.1.2.1 Key primary insights
FIGURE 6 KEY INSIGHTS FROM PRIMARY SOURCES
    2.1.2.2 Breakdown of Primary Interviews
FIGURE 7 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
  2.2.1 BOTTOM-UP APPROACH
FIGURE 8 PROBIOTICS MARKET: BOTTOM-UP APPROACH
  2.2.2 TOP-DOWN APPROACH
    2.2.2.1 Supply side analysis
FIGURE 9 PROBIOTICS MARKET SIZE CALCULATION STEPS AND THEIR CORRESPONDING SOURCES: SUPPLY SIDE
FIGURE 10 PROBIOTICS MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 11 DATA TRIANGULATION
2.4 RESEARCH ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
FIGURE 12 RESEARCH LIMITATIONS & ASSOCIATED RISKS
2.6 RECESSION IMPACT ON PROBIOTICS MARKET
  2.6.1 RECESSION MACROECONOMIC INDICATORS
FIGURE 13 INDICATORS OF RECESSION
FIGURE 14 GLOBAL INFLATION RATE, 2011–2022
FIGURE 15 GLOBAL GDP, 2011–2022 (USD TRILLION)
FIGURE 16 RECESSION INDICATORS AND THEIR IMPACT ON PROBIOTICS MARKET
FIGURE 17 PROBIOTICS MARKET: EARLIER FORECAST VS RECESSION IMPACT FORECAST, 2024

3 EXECUTIVE SUMMARY

TABLE 2 PROBIOTICS MARKET SNAPSHOT, 2024 VS. 2029
FIGURE 18 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION)
FIGURE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION)
FIGURE 20 PROBIOTICS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
FIGURE 21 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION)
FIGURE 22 PROBIOTICS MARKET SHARE (VALUE), BY REGION, 2023

4 PREMIUM INSIGHTS

4.1 ATTRACTIVE OPPORTUNITIES IN PROBIOTICS MARKET
FIGURE 23 HEALTH BENEFITS ASSOCIATED WITH PROBIOTIC-FORTIFIED FOODS & BEVERAGES TO PROPEL MARKET
4.2 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE AND COUNTRY
FIGURE 24 CHINA AND FUNCTIONAL FOOD & BEVERAGES TO ACCOUNT FOR LARGEST SEGMENTAL SHARES IN ASIA PACIFIC PROBIOTICS MARKET IN 2023
4.3 PROBIOTICS MARKET, BY PRODUCT TYPE
FIGURE 25 FUNCTIONAL FOOD & BEVERAGES SEGMENT TO DOMINATE AMONG PROBIOTIC PRODUCT TYPES IN MARKET DURING FORECAST PERIOD
4.4 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY-PRODUCT SUBTYPE
FIGURE 26 DAIRY PRODUCTS TO HAVE SUBSTANTIAL LEAD OVER OTHER FUNCTIONAL FOOD & BEVERAGES WITH PROBIOTICS DURING FORECAST PERIOD
4.5 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL
FIGURE 27 HYPERMARKETS & SUPERMARKETS TO BE LEADING DISTRIBUTION CHANNELS OF PROBIOTICS DURING FORECAST PERIOD
4.6 PROBIOTICS MARKET, BY END USER
FIGURE 28 HUMAN END USE TO COMMAND LION’S SHARE OVER ANIMAL END USE OF PROBIOTICS DURING STUDY PERIOD
4.7 PROBIOTICS MARKET, BY INGREDIENT
FIGURE 29 BACTERIAL PROBIOTICS TO DOMINATE MARKET DURING FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MACROECONOMIC INDICATORS
  5.2.1 INCREASE IN RETAIL SALES
FIGURE 30 US: RETAIL AND FOOD SERVICE SALES, 2016–2022 (USD BILLION)
  5.2.2 GROWTH OPPORTUNITIES IN DEVELOPING REGIONS SUCH AS ASIA PACIFIC AND SOUTH AMERICA
FIGURE 31 ASIA: ANNUAL GDP GROWTH RATE, BY COUNTRY, 2022
5.3 MARKET DYNAMICS
FIGURE 32 MARKET DYNAMICS
  5.3.1 DRIVERS
    5.3.1.1 Rise in awareness on health benefits associated with probiotic-fortified foods
    5.3.1.2 Participation of international bodies in R&D of probiotic products
    5.3.1.3 Technological advancements in probiotic products
  5.3.2 RESTRAINTS
    5.3.2.1 High R&D costs for developing new probiotic strains
    5.3.2.2 Instances of allergic reactions to some probiotic supplements
    5.3.2.3 Stress factors affecting probiotic efficacy
  5.3.3 OPPORTUNITIES
    5.3.3.1 Ban on use of Antibiotic Growth Promoters (AGPs) in feed in EU
    5.3.3.2 Replacement of pharmaceutical agents by probiotics
    5.3.3.3 Use of yeast probiotics as antibiotics or growth promoters
  5.3.4 CHALLENGES
    5.3.4.1 Complexities in integrating probiotics in functional foods
    5.3.4.2 Intolerance of probiotics to stomach acid and bile

6 INDUSTRY TRENDS

6.1 INTRODUCTION
6.2 VALUE CHAIN ANALYSIS
FIGURE 33 VALUE CHAIN ANALYSIS OF PROBIOTICS MARKET
  6.2.1 RESEARCH & PRODUCT DEVELOPMENT
  6.2.2 SOURCING
  6.2.3 PRODUCTION & PROCESSING
  6.2.4 PACKAGING & STORAGE
  6.2.5 DISTRIBUTION, SALES, AND MARKETING
6.3 SUPPLY CHAIN ANALYSIS
FIGURE 34 SUPPLY CHAIN ANALYSIS OF PROBIOTICS MARKET
6.4 TECHNOLOGY ANALYSIS
  6.4.1 KEY TECHNOLOGIES
    6.4.1.1 Multi-layer embedding
    6.4.1.2 Microencapsulated powder for probiotication in food products
  6.4.2 COMPLEMENTARY TECHNOLOGY
    6.4.2.1 Probiotics and artificial intelligence
6.5 PRICING ANALYSIS
  6.5.1 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGES
TABLE 3 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY FUNCTIONAL FOOD & BEVERAGE PRODUCT, 2024 (USD/TON)
  6.5.2 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE
FIGURE 35 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE, 2022–2024 (USD/TON)
FIGURE 36 AVERAGE SELLING PRICE TRENDS, BY PRODUCT TYPE, 2021-2024 (USD/TON)
TABLE 4 AVERAGE SELLING PRICE TRENDS FOR FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2022–2024 (USD/TON)
TABLE 5 AVERAGE SELLING PRICE TRENDS FOR DIETARY SUPPLEMENTS, BY REGION, 2022–2024 (USD/TON)
TABLE 6 AVERAGE SELLING PRICE TRENDS FOR FEED, BY REGION, 2022–2024 (USD/TON)
6.6 ECOSYSTEM ANALYSIS/MARKET MAP
  6.6.1 SUPPLY-SIDE ANALYSIS
  6.6.2 DEMAND SIDE ANALYSIS
FIGURE 37 PROBIOTICS MARKET MAPPING
FIGURE 38 ECOSYSTEM MAPPING OF PROBIOTICS MARKET
TABLE 7 PROBIOTICS MARKET: SUPPLY CHAIN (ECOSYSTEM)
6.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
FIGURE 39 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
6.8 TRADE DATA ANALYSIS
TABLE 8 EXPORT DATA OF HS CODE 300290 FOR KEY COUNTRIES, 2021–2023 (KG)
TABLE 9 IMPORT DATA OF HS CODE 300290 FOR KEY COUNTRIES, 2021–2023 (KG)
6.9 PATENT ANALYSIS
FIGURE 40 NUMBER OF PATENTS GRANTED BETWEEN 2013 AND 2023
FIGURE 41 TOP 10 INVENTORS WITH HIGHEST NUMBER OF PATENT DOCUMENTS
TABLE 10 KEY PATENTS IN PROBIOTICS MARKET, 2023–2024
6.10 KEY CONFERENCES & EVENTS
6.11 REGULATORY LANDSCAPE
  6.11.1 PERTINENT REGULATORY FACTORS
    6.11.1.1 North america
      6.11.1.1.1 US
      6.11.1.1.2 Canada
    6.11.1.2 Europe
    6.11.1.3 Asia pacific
      6.11.1.3.1 Japan
      6.11.1.3.2 Australia and New Zealand
      6.11.1.3.3 India
    6.11.1.4 South america
      6.11.1.4.1 Brazil
    6.11.1.5 Row
      6.11.1.5.1 Middle East
      6.11.1.5.2 Africa (South Africa)
  6.11.2 REGULATORY BODIES, GOVERNMENT AGENCIES, & OTHER ORGANIZATIONS
TABLE 12 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
6.12 PORTER’S FIVE FORCES ANALYSIS
TABLE 15 PROBIOTICS MARKET: PORTER’S FIVE FORCES ANALYSIS
  6.12.1 THREAT OF NEW ENTRANTS
  6.12.2 THREAT OF SUBSTITUTES
  6.12.3 BARGAINING POWER OF SUPPLIERS
  6.12.4 BARGAINING POWER OF BUYERS
  6.12.5 INTENSITY OF COMPETITIVE RIVALRY
6.13 CASE STUDIES
  6.13.1 ADM: PROMOTED METABOLIC HEALTH WITH BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS CECT 8145 BPL1
  6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH: PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING
6.14 KEY STAKEHOLDERS AND BUYING CRITERIA
  6.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 42 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR KEY PRODUCT TYPE
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP THREE PRODUCT TYPES
  6.14.2 BUYING CRITERIA
TABLE 17 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE
FIGURE 43 KEY CRITERIA FOR SELECTING SUPPLIERS/VENDORS, BY PRODUCT TYPE
6.15 INVESTMENT AND FUNDING SCENARIO
FIGURE 44 INVESTMENT AND FUNDING SCENARIO

7 PROBIOTICS MARKET, BY PRODUCT TYPE

7.1 INTRODUCTION
FIGURE 45 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024 VS. 2029 (USD BILLION)
TABLE 18 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 19 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 20 PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 21 PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
7.2 FUNCTIONAL FOOD & BEVERAGES
FIGURE 46 US: PREFERRED SOURCES OF PROBIOTICS CONSUMPTION, 2022
TABLE 22 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (USD BILLION)
TABLE 23 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (USD BILLION)
TABLE 24 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2020–2023 (KT)
TABLE 25 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY REGION, 2024–2029 (KT)
TABLE 26 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 27 PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
  7.2.1 DAIRY PRODUCTS
    7.2.1.1 Popularity of dairy products and high compatibility with probiotics
  7.2.2 NONDAIRY BEVERAGES
    7.2.2.1 Need to cater to increasing lactose-intolerant consumers
  7.2.3 INFANT FORMULA
    7.2.3.1 Rise in consumption of fortified infant nutrition
  7.2.4 CEREALS
    7.2.4.1 Rise in demand for ready-to-eat food items with changing consumer lifestyles
  7.2.5 OTHER FUNCTIONAL FOOD & BEVERAGES
7.3 DIETARY SUPPLEMENTS
TABLE 28 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (USD BILLION)
TABLE 29 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (USD BILLION)
TABLE 30 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2020–2023 (KT)
TABLE 31 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY REGION, 2024–2029 (KT)
TABLE 32 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 33 PROBIOTICS MARKET IN DIETARY SUPPLEMENTS, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
  7.3.1 TABLETS
    7.3.1.1 High shelf-life, affordability, and wide range of dosage patterns
  7.3.2 CAPSULES
    7.3.2.1 Rapid absorption of nutrients and highly customizable
  7.3.3 POWDERS
    7.3.3.1 Easy release of active ingredients and high stability
  7.3.4 LIQUIDS
    7.3.4.1 Easy consumption, greater homogeneity, and high absorption in bloodstreams
  7.3.5 SOFT GELS
    7.3.5.1 Relatively low cost and improved bioavailability
  7.3.6 GEL CAPS
    7.3.6.1 Pure-protein, benign oral dosage form
7.4 FEED
  7.4.1 RISE IN TREND FOR PROVIDING PETS WITH HIGH-QUALITY AND HEALTHY WET AND DRY MEALS
TABLE 34 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (USD BILLION)
TABLE 35 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (USD BILLION)
TABLE 36 PROBIOTICS MARKET IN FEED, BY REGION, 2020–2023 (KT)
TABLE 37 PROBIOTICS MARKET IN FEED, BY REGION, 2024–2029 (KT)

8 PROBIOTICS MARKET, BY INGREDIENT

8.1 INTRODUCTION
TABLE 38 DIVERSITY OF PROBIOTICS
TABLE 39 HEALTH BENEFITS OF PROBIOTIC MICROORGANISMS
FIGURE 47 PROBIOTICS MARKET, BY INGREDIENT, 2024 VS. 2029 (USD BILLION)
TABLE 40 PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 41 PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
8.2 BACTERIA
TABLE 42 BACTERIAL PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 43 BACTERIAL PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 44 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION)
TABLE 45 BACTERIAL PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION)
  8.2.1 LACTOBACILLI
    8.2.1.1 Lactobacillus acidophilus
      8.2.1.1.1 Rise in consumption of fermented foods, cheese, and yogurt
    8.2.1.2 Lactobacillus rhamnosus
      8.2.1.2.1 Ability to endure harsh gut conditions and reduced risk of antibiotic-associated intestinal symptoms
    8.2.1.3 Lactobacillus casei
      8.2.1.3.1 Broad-spectrum action against diseases caused by gastrointestinal pathogenic bacteria
    8.2.1.4 Lactobacillus reuteri
      8.2.1.4.1 Opportunities in preventive and therapeutic avenues against inflammatory diseases
  8.2.2 BIFIDOBACTERIUM
    8.2.2.1 Benefits against chronic ailments, especially in infant gut health
  8.2.3 STREPTOCOCCUS THERMOPHILUS
    8.2.3.1 Growing application of Streptococcus thermophilus in food and feed industries
8.3 YEAST
TABLE 46 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 47 YEAST-BASED PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 48 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2020–2023 (USD BILLION)
TABLE 49 YEAST-BASED PROBIOTICS MARKET, BY TYPE, 2024–2029 (USD BILLION)
TABLE 50 BENEFICIAL EFFECTS OF YEAST
  8.3.1 SACCHAROMYCES BOULARDII
    8.3.1.1 GI stress-resistance key in maintaining gut flora balance
  8.3.2 OTHER YEASTS

9 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL

9.1 INTRODUCTION
FIGURE 48 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024 VS. 2029 (USD BILLION)
TABLE 51 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 52 PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
9.2 HYPERMARKETS/SUPERMARKETS
  9.2.1 EXPANSION OF SUPERMARKETS IN ASIA PACIFIC
TABLE 53 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2020–2023 (USD BILLION)
TABLE 54 PROBIOTICS MARKET IN HYPERMARKETS/SUPERMARKETS, BY REGION, 2024–2029 (USD BILLION)
9.3 PHARMACIES/DRUGSTORES
  9.3.1 RISE IN AWARENESS FOR PROBIOTIC SUPPLEMENTS IN DEVELOPED COUNTRIES TO POPULARIZE PHARMACIES
TABLE 55 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2020–2023 (USD BILLION)
TABLE 56 PROBIOTICS MARKET IN PHARMACIES/DRUGSTORES, BY REGION, 2024–2029 (USD BILLION)
9.4 SPECIALTY STORES
  9.4.1 PROBIOTIC SALES FUELED BY PROPER STORAGE AND TRANSPARENT LABELING
TABLE 57 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2020–2023 (USD BILLION)
TABLE 58 PROBIOTICS MARKET IN SPECIALTY STORES, BY REGION, 2024–2029 (USD BILLION)
9.5 ONLINE
  9.5.1 ONLINE SALES SURGE DUE TO CONVENIENCE, HEALTH FOCUS, AND STRONG BRAND LOYALTY AMONG CONSUMERS
TABLE 59 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2020–2023 (USD BILLION)
TABLE 60 PROBIOTICS MARKET IN ONLINE CHANNELS, BY REGION, 2024–2029 (USD BILLION)
9.6 CONVENIENCE STORES/SMALL RETAIL FORMATS
  9.6.1 EASY ACCESS FOR CONSUMERS ENCOURAGING PURCHASE
TABLE 61 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2020–2023 (USD BILLION)
TABLE 62 PROBIOTICS MARKET IN CONVENIENCE STORES/SMALL RETAIL FORMATS, BY REGION, 2024–2029 (USD BILLION)

10 PROBIOTICS MARKET, BY END USER

10.1 INTRODUCTION
FIGURE 49 HUMAN CONSUMPTION TO DOMINATE MARKET FROM 2024 TO 2029 (USD BILLION)
TABLE 63 PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 64 PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
10.2 HUMAN
  10.2.1 RISING TREND OF CONSUMING FUNCTIONAL FOODS DUE TO HEALTH CONSCIOUSNESS
FIGURE 50 FREQUENCY OF PROBIOTIC CONSUMPTION AMONG USERS
TABLE 65 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2020–2023 (USD BILLION)
TABLE 66 PROBIOTICS MARKET FOR HUMAN USE, BY REGION, 2024–2029 (USD BILLION)
10.3 ANIMAL
  10.3.1 BAN ON SYNTHETIC ANTIBIOTICS TO BOOST MARKET IN FEED
TABLE 67 BENEFITS ASSOCIATED WITH ADMINISTRATION OF PROBIOTICS IN ANIMAL FEED
TABLE 68 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2020–2023 (USD BILLION)
TABLE 69 PROBIOTICS MARKET FOR ANIMAL USE, BY REGION, 2024–2029 (USD BILLION)

11 PROBIOTICS MARKET, BY REGION

11.1 INTRODUCTION
FIGURE 51 RAPIDLY GROWING MARKETS TO EMERGE AS NEW HOT SPOTS
TABLE 70 PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 71 PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 72 PROBIOTICS MARKET, BY REGION, 2020–2023 (KT)
TABLE 73 PROBIOTICS MARKET, BY REGION, 2024–2029 (KT)
11.2 NORTH AMERICA
  11.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 52 NORTH AMERICA: INFLATION DATA, BY KEY COUNTRY, 2017–2022
FIGURE 53 NORTH AMERICA: RECESSION IMPACT ANALYSIS
TABLE 74 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION)
TABLE 75 NORTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION)
TABLE 76 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 77 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 78 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 79 NORTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 80 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 81 NORTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 82 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 83 NORTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 84 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 85 NORTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 86 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 87 NORTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
  11.2.2 US
    11.2.2.1 Rise in digestive health awareness
TABLE 88 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 89 US: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.2.3 CANADA
    11.2.3.1 Demand for high-quality and innovative feed products to accelerate probiotics production and consumption
TABLE 90 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 91 CANADA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.2.4 MEXICO
    11.2.4.1 Consumer inclination toward healthy diets
TABLE 92 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 93 MEXICO: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
11.3 EUROPE
FIGURE 54 EUROPE: MARKET SNAPSHOT
  11.3.1 EUROPE: RECESSION IMPACT ANALYSIS
FIGURE 55 EUROPE: INFLATION DATA, BY KEY COUNTRY, 2017–2022
FIGURE 56 EUROPE: RECESSION IMPACT ANALYSIS
TABLE 94 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION)
TABLE 95 EUROPE: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION)
TABLE 96 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 97 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 98 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 99 EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 100 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 101 EUROPE: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 102 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 103 EUROPE: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 104 EUROPE: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 105 EUROPE: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 106 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 107 EUROPE: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
  11.3.2 RUSSIA
    11.3.2.1 Highly regulated probiotic landscape
TABLE 108 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 109 RUSSIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.3.3 UK
    11.3.3.1 Shift toward natural foods that support digestive health
TABLE 110 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 111 UK: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.3.4 ITALY
    11.3.4.1 Preference for cheese and awareness about health benefits of probiotics
TABLE 112 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 113 ITALY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.3.5 GERMANY
    11.3.5.1 Preference for probiotic yogurts and yogurt drinks and opportunity for use in poultry feed
TABLE 114 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 115 GERMANY: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.3.6 SPAIN
    11.3.6.1 Growing interest in health and wellness products among consumers to spur investment by companies
TABLE 116 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 117 SPAIN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.3.7 REST OF EUROPE
TABLE 118 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 119 REST OF EUROPE: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 57 ASIA PACIFIC: MARKET SNAPSHOT
  11.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
FIGURE 58 ASIA PACIFIC: INFLATION DATA, BY KEY COUNTRY, 2017–2022
FIGURE 59 ASIA PACIFIC: RECESSION IMPACT ANALYSIS
TABLE 120 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2020–2023 (USD BILLION)
TABLE 121 ASIA PACIFIC: PROBIOTICS MARKET, BY COUNTRY/REGION, 2024–2029 (USD BILLION)
TABLE 122 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 123 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 124 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 125 ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 126 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 127 ASIA PACIFIC: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 128 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 129 ASIA PACIFIC: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 130 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 131 ASIA PACIFIC: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 132 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 133 ASIA PACIFIC: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
  11.4.2 CHINA
    11.4.2.1 Strategic moves by players to tap high sales potential of probiotics
TABLE 134 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 135 CHINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.4.3 JAPAN
    11.4.3.1 Focus on digestive well-being of aging population
TABLE 136 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 137 JAPAN: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.4.4 INDIA
    11.4.4.1 Increased focus on women’s nutrition and post-COVID-19 consumer preference for functional food
TABLE 138 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 139 INDIA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.4.5 AUSTRALIA & NEW ZEALAND
    11.4.5.1 Aging population and consumer awareness to drive clinical trials and retail sales
TABLE 140 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 141 AUSTRALIA & NEW ZEALAND: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.4.6 REST OF ASIA PACIFIC
TABLE 142 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 143 REST OF ASIA PACIFIC: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
11.5 SOUTH AMERICA
  11.5.1 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
FIGURE 60 SOUTH AMERICA: INFLATION DATA, BY COUNTRY, 2017–2022
FIGURE 61 SOUTH AMERICA: RECESSION IMPACT ANALYSIS
TABLE 144 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2020–2023 (USD BILLION)
TABLE 145 SOUTH AMERICA: PROBIOTICS MARKET, BY COUNTRY, 2024–2029 (USD BILLION)
TABLE 146 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 147 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 148 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 149 SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 150 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 151 SOUTH AMERICA: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 152 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 153 SOUTH AMERICA: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 154 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 155 SOUTH AMERICA: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 156 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 157 SOUTH AMERICA: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
  11.5.2 BRAZIL
    11.5.2.1 Rise in health awareness and meat exports to EU
TABLE 158 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 159 BRAZIL: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.5.3 ARGENTINA
    11.5.3.1 Increase in industrialization of meat processing and dairy productivity
TABLE 160 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 161 ARGENTINA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.5.4 REST OF SOUTH AMERICA
TABLE 162 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 163 REST OF SOUTH AMERICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
11.6 REST OF THE WORLD (ROW)
  11.6.1 ROW: RECESSION IMPACT ANALYSIS
FIGURE 62 ROW: INFLATION DATA, BY SUBREGION, 2017–2022
FIGURE 63 ROW: RECESSION IMPACT ANALYSIS
TABLE 164 ROW: PROBIOTICS MARKET, BY REGION, 2020–2023 (USD BILLION)
TABLE 165 ROW: PROBIOTICS MARKET, BY REGION, 2024–2029 (USD BILLION)
TABLE 166 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD BILLION)
TABLE 167 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD BILLION)
TABLE 168 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (KT)
TABLE 169 ROW: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (KT)
TABLE 170 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2020–2023 (USD BILLION)
TABLE 171 ROW: PROBIOTICS MARKET IN FUNCTIONAL FOOD & BEVERAGES, BY PRODUCT SUBTYPE, 2024–2029 (USD BILLION)
TABLE 172 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2020–2023 (USD BILLION)
TABLE 173 ROW: PROBIOTICS MARKET, BY DISTRIBUTION CHANNEL, 2024–2029 (USD BILLION)
TABLE 174 ROW: PROBIOTICS MARKET, BY END USER, 2020–2023 (USD BILLION)
TABLE 175 ROW: PROBIOTICS MARKET, BY END USER, 2024–2029 (USD BILLION)
TABLE 176 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2020–2023 (USD BILLION)
TABLE 177 ROW: PROBIOTICS MARKET, BY INGREDIENT, 2024–2029 (USD BILLION)
  11.6.2 MIDDLE EAST
    11.6.2.1 Demand for quality feed, high consumption of feed, and demand for yogurt
TABLE 178 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 179 MIDDLE EAST: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)
  11.6.3 AFRICA
    11.6.3.1 Investments in pharmaceutical companies to increase with intra-African trade
TABLE 180 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2020–2023 (USD MILLION)
TABLE 181 AFRICA: PROBIOTICS MARKET, BY PRODUCT TYPE, 2024–2029 (USD MILLION)

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
12.2 SEGMENTAL REVENUE ANALYSIS
FIGURE 64 SEGMENTAL REVENUE ANALYSIS OF KEY MARKET PLAYERS, 2018–2022 (USD BILLION)
12.3 MARKET SHARE ANALYSIS
TABLE 182 PROBIOTICS MARKET: DEGREE OF COMPETITION (COMPETITIVE)
12.4 KEY PLAYERS’ STRATEGIES/RIGHT TO WIN
TABLE 183 STRATEGIES ADOPTED BY KEY PLAYERS IN PROBIOTICS MARKET
12.5 COMPANY VALUATION AND FINANCIAL METRICS
FIGURE 65 PROBIOTICS MARKET: COMPANY VALUATION (USD BILLION)
FIGURE 66 PROBIOTICS MARKET: EV/EBITDA, 2022 (USD BILLION)
12.6 BRAND/PRODUCT COMPARISON
FIGURE 67 PROBIOTICS MARKET: BRAND/PRODUCT COMPARISON
  12.6.1 DIVERSE PROBIOTIC SOLUTIONS FUELING MARKET GROWTH
    12.6.1.1 Nestlй Cerelac
    12.6.1.2 Danone’s Activia
    12.6.1.3 Yakult
    12.6.1.4 LG21 by Meiji Holding Inc.
    12.6.1.5 HOWARU by IFF Health
12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS
  12.7.1 STARS
  12.7.2 EMERGING LEADERS
  12.7.3 PERVASIVE PLAYERS
  12.7.4 PARTICIPANTS
FIGURE 68 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2023
  12.7.5 COMPANY FOOTPRINT: KEY PLAYERS
    12.7.5.1 Overall company footprint
FIGURE 69 PROBIOTICS MARKET: OVERALL COMPANY FOOTPRINT FOR KEY PLAYERS, 2023
    12.7.5.2 Product type footprint
TABLE 184 PROBIOTICS MARKET: PRODUCT TYPE FOOTPRINT FOR KEY PLAYERS, 2023
    12.7.5.3 End user footprint
TABLE 185 PROBIOTICS MARKET: END USER FOOTPRINT FOR KEY PLAYERS, 2023
    12.7.5.4 Regional footprint
TABLE 186 PROBIOTICS MARKET: REGIONAL FOOTPRINT FOR KEY PLAYERS, 2023
12.8 COMPANY EVALUATION MATRIX: STARTUP/SMES
  12.8.1 PROGRESSIVE COMPANIES
  12.8.2 RESPONSIVE COMPANIES
  12.8.3 DYNAMIC COMPANIES
  12.8.4 STARTING BLOCKS
FIGURE 70 PROBIOTICS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2023
  12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES
    12.8.5.1 Detailed list of key startup/smes
TABLE 187 PROBIOTICS MARKET: KEY STARTUP/SMES, 2023
    12.8.5.2 Competitive benchmarking of key startup/smes
TABLE 188 PROBIOTICS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUP/SMES
12.9 COMPETITIVE SCENARIO AND TRENDS
  12.9.1 PRODUCT LAUNCHES
TABLE 189 PROBIOTICS MARKET: PRODUCT LAUNCHES, JANUARY 2019–FEBRUARY 2024
  12.9.2 DEALS
TABLE 190 PROBIOTICS MARKET: DEALS, JANUARY 2019–FEBRUARY 2024
  12.9.3 OTHERS
TABLE 191 PROBIOTICS MARKET: EXPANSIONS, JANUARY 2019–FEBRUARY 2024
TABLE 192 PROBIOTICS MARKET: OTHERS, JANUARY 2019–FEBRUARY 2024

13 COMPANY PROFILES

13.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
  13.1.1 PROBI
TABLE 193 PROBI: BUSINESS OVERVIEW
FIGURE 71 PROBI: COMPANY SNAPSHOT
TABLE 194 PROBI: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 195 PROBI: PRODUCT LAUNCHES
TABLE 196 PROBI: DEALS
  13.1.2 NESTLЙ
TABLE 197 NESTLЙ: BUSINESS OVERVIEW
FIGURE 72 NESTLЙ: COMPANY SNAPSHOT
TABLE 198 NESTLЙ: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 199 NESTLЙ: PRODUCT LAUNCHES
TABLE 200 NESTLЙ: DEALS
  13.1.3 ADM
TABLE 201 ADM: BUSINESS OVERVIEW
FIGURE 73 ADM: COMPANY SNAPSHOT
TABLE 202 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 203 ADM: DEALS
TABLE 204 ADM: EXPANSIONS
  13.1.4 DANONE
TABLE 205 DANONE: BUSINESS OVERVIEW
FIGURE 74 DANONE: COMPANY SNAPSHOT
TABLE 206 DANONE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 207 DANONE: PRODUCT LAUNCHES
TABLE 208 DANONE: EXPANSIONS
  13.1.5 INTERNATIONAL FLAVORS & FRAGRANCES INC.
TABLE 209 INTERNATIONAL FLAVORS & FRAGRANCES INC.: BUSINESS OVERVIEW
FIGURE 75 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
TABLE 210 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 211 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
TABLE 212 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS
  13.1.6 YAKULT HONSHA CO., LTD.
TABLE 213 YAKULT HONSHA CO., LTD.: BUSINESS OVERVIEW
FIGURE 76 YAKULT HONSHA CO., LTD.: COMPANY SNAPSHOT
TABLE 214 YAKULT HONSHA CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 215 YAKULT HONSHA CO., LTD.: PRODUCT LAUNCHES
TABLE 216 YAKULT HONSHA CO., LTD.: DEALS
TABLE 217 YAKULT HONSHA CO., LTD.: EXPANSIONS
  13.1.7 BIOGAIA
TABLE 218 BIOGAIA: BUSINESS OVERVIEW
FIGURE 77 BIOGAIA: COMPANY SNAPSHOT
TABLE 219 BIOGAIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 220 BIOGAIA: PRODUCT LAUNCHES
TABLE 221 BIOGAIA: DEALS
TABLE 222 BIOGAIA: EXPANSIONS
  13.1.8 MORINAGA MILK INDUSTRY CO., LTD.
TABLE 223 MORINAGA MILK INDUSTRY CO., LTD.: BUSINESS OVERVIEW
FIGURE 78 MORINAGA MILK INDUSTRY CO., LTD.: COMPANY SNAPSHOT
TABLE 224 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 225 MORINAGA MILK INDUSTRY CO., LTD.: PRODUCT LAUNCHES
TABLE 226 MORINAGA MILK INDUSTRY CO., LTD.: OTHERS
TABLE 227 MORINAGA MILK INDUSTRY CO., LTD.: EXPANSIONS
  13.1.9 MEIJI HOLDINGS CO., LTD.
TABLE 228 MEIJI HOLDINGS CO., LTD.: BUSINESS OVERVIEW
FIGURE 79 MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT
TABLE 229 MEIJI HOLDINGS CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  13.1.10 LIFEWAY FOODS, INC.
TABLE 230 LIFEWAY FOODS, INC.: BUSINESS OVERVIEW
FIGURE 80 LIFEWAY FOODS, INC.: COMPANY SNAPSHOT
TABLE 231 LIFEWAY FOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 232 LIFEWAY FOODS, INC.: DEALS
  13.1.11 ADISSEO
TABLE 233 ADISSEO: BUSINESS OVERVIEW
FIGURE 81 ADISSEO: COMPANY SNAPSHOT
TABLE 234 ADISSEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  13.1.12 WINCLOVE PROBIOTICS
TABLE 235 WINCLOVE PROBIOTICS: BUSINESS OVERVIEW
TABLE 236 WINCLOVE PROBIOTICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 237 WINCLOVE PROBIOTICS: DEALS
TABLE 238 WINCLOVE PROBIOTICS: EXPANSIONS
  13.1.13 AB-BIOTICS, S.A.
TABLE 239 AB-BIOTICS, S.A.: BUSINESS OVERVIEW
TABLE 240 AB-BIOTICS, S.A.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 241 AB-BIOTICS, S.A.: DEALS
  13.1.14 APSEN FARMAC?UTICA
TABLE 242 APSEN FARMAC?UTICA: BUSINESS OVERVIEW
TABLE 243 APSEN FARMAC?UTICA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 244 APSEN FARMAC?UTICA: PRODUCT LAUNCHES
TABLE 245 APSEN FARMAC?UTICA: DEALS
  13.1.15 LALLEMAND
TABLE 246 LALLEMAND: BUSINESS OVERVIEW
TABLE 247 LALLEMAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 248 LALLEMAND: DEALS
TABLE 249 LALLEMAND: EXPANSIONS
13.2 STARTUP/SME PLAYERS
  13.2.1 ELANCO
TABLE 250 ELANCO: BUSINESS OVERVIEW
FIGURE 82 ELANCO: COMPANY SNAPSHOT
TABLE 251 ELANCO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  13.2.2 NEXTFOODS, INC.
TABLE 252 NEXTFOODS, INC.: BUSINESS OVERVIEW
TABLE 253 NEXTFOODS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 NEXTFOODS, INC.: DEALS
  13.2.3 I-HEALTH, INC.
TABLE 255 I-HEALTH, INC.: BUSINESS OVERVIEW
TABLE 256 I-HEALTH, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  13.2.4 SUJA LIFE, LLC.
TABLE 257 SUJA LIFE, LLC.: BUSINESS OVERVIEW
TABLE 258 SUJA LIFE, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 259 SUJA LIFE, LLC.: DEALS
  13.2.5 RENEW LIFE FORMULAS, LLC
TABLE 260 RENEW LIFE FORMULAS, LLC.: BUSINESS OVERVIEW
TABLE 261 RENEW LIFE FORMULAS, LLC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  13.2.6 BIOHM HEALTH
TABLE 262 BIOHM HEALTH: BUSINESS OVERVIEW
  13.2.7 SUN GENOMICS
TABLE 263 SUN GENOMICS: BUSINESS OVERVIEW
  13.2.8 UNIQUE BIOTECH LTD
TABLE 264 UNIQUE BIOTECH LTD: BUSINESS OVERVIEW
  13.2.9 SO GOOD SO YOU
TABLE 265 SO GOOD SO YOU: BUSINESS OVERVIEW
  13.2.10 PROTOCOL FOR LIFE BALANCE
TABLE 266 PROTOCOL FOR LIFE BALANCE: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 ADJACENT AND RELATED MARKETS

14.1 INTRODUCTION
TABLE 267 ADJACENT MARKETS TO PROBIOTICS
14.2 RESEARCH LIMITATIONS
14.3 DIETARY SUPPLEMENT MARKET
  14.3.1 MARKET DEFINITION
  14.3.2 MARKET OVERVIEW
TABLE 268 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2018–2022 (USD MILLION)
TABLE 269 DIETARY SUPPLEMENTS MARKET, BY TYPE, 2023–2028 (USD MILLION)
14.4 BONE & JOINT HEALTH SUPPLEMENTS MARKET
  14.4.1 MARKET DEFINITION
  14.4.2 MARKET OVERVIEW
TABLE 270 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2017–2021 (USD MILLION)
TABLE 271 BONE & JOINT HEALTH SUPPLEMENTS MARKET, BY TYPE, 2022–2027 (USD MILLION)

15 APPENDIX

15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS

The probiotics market is currently being driven by the rising popularity of probiotic functional foods and beverages among (F&B) consumers. Age, stress, poor diet, etc. are some  of the reasons  responsible  for  digestive  ailments,  bloating,  reduced  resistance  to  infections,  etc.; consumption  of  probiotic  enhanced  products  helps  to  alleviate  these  widespread  conditions.

These products contain live microorganisms (probiotics) that confer positive health effect on the host.  Companies  such  as  Yakult  Honsha  (Japan)  and  Chr.  Hansen  (Denmark)  have developed patented strains of microorganisms claiming to affect specific health benefits; there has  been  a  proliferation  of  probiotic  ingredient  suppliers  who  develop  tailored  strains  of microorganisms  for  integrating  with  a  diverse  set  of  products.  Awareness, faith on their efficacy, and safety are some of the deciding factors for the success of probiotic products. The market  for  overall probiotic products  was  $XX billion in  2012  and is  expected  to  grow  at  a CAGR of XX% from 2014 to 2019 to reach a size of $XX billion by 2019.

High awareness of probiotics yoghurt and fermented milk in Asia-Pacific makes it the largest market  for  probiotics.  Europe  is  the  second-largest  market  for  probiotics.  The  probiotics market  is  growing  rapidly  in  the  U.S.  as  well;  the  general  affinity  of  the  U.S.  population towards probiotic dietary supplements and the concept of preventive health care are expected to drive the market in future; the sales of probiotic yogurts are already on the rise. The overall probiotic yogurt market is expected to reach a market size of $XX billion by 2019 growing at a CAGR  of  XX%  from  2014  to  2019.  The  market  size  of  probiotic  dietary  supplements  is expected to be about $XX billion by 2019 growing at a CAGR of XX%.

By  ingredient,  the  probiotic  bacteria  dominated  the  market  share  with  XX%.  Lactobacilli dominated bacterial probiotic ingredient with a share of XX% in 2013. Following lactobacilli, bifidobacteria was the second-largest sub-type of bacterial probiotic ingredient with a share of XX% in 2013.

Asia-Pacific dominated the probiotic lactobacilli market with XX% of the global share, followed by  Europe  with  a  share  of  about  XX%  in  2013.  Lactobacillus  acidophilus  dominated  the lactobacilli  market  with  a  share  of  XX%.  Lactobacillus  rhamnosus  accounted  for  a  share  of XX% in 2013.



More Publications